Analytical Data
-
Gene name
Fam83d
- Application
-
Alternative Names
Fam83dProtein FAM83D
-
Species
Mouse
-
Source
Yeast
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9D7I8
-
Expression Region
1-585aa
-
Molecular Weight
66.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on the recombinant protein Fam83d has gained significant attention due to its potential roles in various biological processes and its implications in disease mechanisms. Fam83d, a member of the Fam83 family, has been implicated in cell proliferation, differentiation, and signaling pathways, particularly those associated with cancer progression. Studies have shown that aberrant expression of Fam83d can influence tumorigenesis, making it a candidate for cancer biomarker development and therapeutic target exploration. Additionally, the protein is thought to interact with various signaling molecules, impacting pathways such as the RAS/RAF/MEK/ERK cascade, which is crucial in many malignancies. Recombinant protein technology allows for the production of large quantities of Fam83d, enabling detailed studies of its structure, function, and interactions at the molecular level. Understanding the role of Fam83d in cellular processes could provide insights into its potential as a target for drug development and contribute to the advancement of personalized medicine approaches in oncology. As such, ongoing research into Fam83d promises to illuminate new avenues for therapeutic intervention, with the goal of improving outcomes for patients with cancer and other related diseases.
